|
1. MRI
Diagnosis of Accreta By Andrew D. Hull and Michele A. Brown
2. Decreased fetal movement protocol did not
reduce fetal death (October 2018)
3. Timing of Tdap vaccination during pregnancy
(October 2018)
4. Low-dose aspirin and spontaneous preterm
birth (October 2018)
5. Choice of follow-up testing after a positive
first-trimester Down syndrome screening test (August 2018)
6. Maternal antenatal exposure to sildenafil
and risk for neonatal death (August 2018)
7. Cervical pessary after arrested preterm
labour does not improve neonatal outcome (July 2018)
8. Nonsteroidal anti-inflammatory drugs and
risk of miscarriage (July 2018)
9. Platelet counts in pregnancy (July 2018)
10. AASLD/IDSA recommendations on HCV screening
during pregnancy (June 2018)
11. Targets for blood pressure control during
pregnancy (May 2018)
12. Glyburide versus insulin for treatment of
gestational diabetes (May 2018)
13. Prenatal caffeine consumption and postnatal growth in
offspring (April 2018)
14. Immediate versus delayed pushing (October 2018)
15. Intravenous versus intramuscular oxytocin for prevention
of postpartum hemorrhage (September 2018)
16. Discontinuation of oxytocin in the active phase during
induction (September 2018)
17. Guidelines for regional anaesthesia in patients
receiving antithrombotic or thrombolytic medications (August
2018)
18. Prophylactic use of tranexamic acid at vaginal delivery
(August 2018)
19. Uterotonic drugs for preventing postpartum hemorrhage
(August 2018)
20. Balloon catheter volume for cervical ripening (August
2018)
21. ACOG endorses shared decision-making for elective
induction at 39 weeks (August 2018)
22. Neuraxial analgesia and risk of operative vaginal
delivery (August 2018)
23. Heat-stable carbetocin for prevention of postpartum
hemorrhage (July 2018)
24. Pregnancy-related hypertensive disorders and risk for
cardiovascular disease (July 2018)
|
